Related Experiment Videos
Tumoral calcinosis. Observations during six years
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|January 1, 1980
Summary
This study presents a rare case of tumoral calcinosis in a 56-year-old woman. Tumor reduction was observed under negative calcium-phosphorus balance, with no significant acceleration from ethane-hydroxy-diphosphonate treatment.
Area of Science:
- Nephrology
- Endocrinology
- Rheumatology
Background:
- Presents findings on a 56-year-old woman with tumoral calcinosis, a rare condition characterized by calcium salt deposits.
- Details a 6-year treatment course, highlighting the complexities of managing this disorder.
Observation:
- Tumor size reduction was observed when the patient was in a negative calcium-phosphorus balance.
- Transient hypercalcemia occurred, attributed to immobilization during the treatment period.
Findings:
- Treatment with ethane-hydroxy-diphosphonate (EHDP) at 500 mg/day for 20 months did not definitively accelerate tumor reduction.
- The patient developed nephrotic syndrome secondary to amyloidosis, likely stemming from the aseptic histiocytic inflammatory process within the tumors.
Implications:
- This case underscores the challenges in managing tumoral calcinosis and its associated complications.
- Highlights the potential link between chronic inflammation in tumoral calcinosis and the development of secondary amyloidosis.
- Suggests further investigation into the role of lipid profiles, specifically high cholesterol in very low-density lipoproteins, in patients with tumoral calcinosis.